European Archives of Oto-Rhino-Laryngology

, Volume 270, Issue 6, pp 1789–1793 | Cite as

Protective effects of resveratrol on cisplatin-dependent inner-ear damage in rats

  • Gökçe ŞimşekEmail author
  • Sibel Alicura Tokgoz
  • Erkan Vuralkan
  • Murat Caliskan
  • Omer Besalti
  • Istemihan Akin


Cisplatin is a common chemotherapeutic agent used in many solid and hematologic malignancies. The main unwanted effect of cisplatin is ototoxicity, for which no standard treatment has been reported. The present study examined the protective efficacy of resveratrol on cisplatin-dependent ototoxicity through an experimental model. Fifteen rats were randomized into three groups. Group 1 (control group) (n = 5) received intraperitoneal (i.p.) 15 mg/kg cisplatin; group 2 (resveratrol group) (n = 5) received i.p. 100 mg/kg resveratrol, followed by i.p. 15 mg/kg cisplatin; group 3 (n = 5) served as a vehicle group and received i.p. 1 ml dimethyl sulfoxide. All rats underwent the auditory brainstem response (ABR) test before and 72 h after the treatment. Pretreatment ABR values of the groups were not significantly different. The pretreatment hearing threshold values of the groups were 30 ± 6.60 and 28.5 ± 5.29 dB in groups 1 and 2, respectively (p > 0.05). The post-ABR-I and post-ABR-IV values were, respectively, 1.41 ± 0.18 and 5.83 ± 0.16 ms in the control subjects and 1.19 ± 0.22 and 4.58 ± 0.27 ms in the study group. The ABR-I and ABR-IV durations in rats treated with resveratrol were significantly shorter (p < 0.01). A comparison of threshold values shows that the resveratrol-treated rats had significantly lower values than the control rats. After cisplatin injection, ABR I–IV intervals were compared among the groups. The ABR I–IV interval duration was 4.42 ± 0.16 ms in the control group, while the resveratrol-treated rats showed a significantly shorter ABR I–IV interval duration of 3.49 ± 0.27 ms (p < 0.001). Resveratrol attenuated cisplatin-dependent inner-ear damage, as shown by the ABR-I, ABR-IV, ABR I–IV interval, and hearing threshold values. Our results suggest that this natural antioxidant may be effectively used in reducing the unwanted effects of cisplatin on the ear physiology of patients, particularly those undergoing chemotherapy.


Ototoxicity Cisplatin Resveratrol ABR 



The authors in this manuscript indicate that they do not have any financial relationship with the organization that sponsored the research.


  1. 1.
    Boulikas T, Vougiouka M (2004) Recent clinical trail using sisplatin, karboplatin and their combination chemotherapy drugs. Oncol Rep 11:559–595PubMedGoogle Scholar
  2. 2.
    Meech RP, Campbell KC, Hughes LP et al (1998) A semiquantitative analysis of the effects of sisplatin on the rat stria vascularis. Hear Res 124:44–59PubMedCrossRefGoogle Scholar
  3. 3.
    Ravi R, Somani SM, Rybak LP (1995) Mechanism of sisplatin ototoxicity: antioxidant system. Pharmacol Toxicol 76:386–394PubMedCrossRefGoogle Scholar
  4. 4.
    Rybak LP, Whitworth C, Somani S (1999) Satu: application of antioxidants and other agents to prevent sisplatin ototoxicity. Laryngoscope 109:1740–1744PubMedCrossRefGoogle Scholar
  5. 5.
    Vidavalur R, Otani H, Singal PK, Maulik N (2006) Significance of wine and resveratrol in cardiovascular disease: French paradox revisited. Exp Clin Cardiol 11(3):217–225PubMedGoogle Scholar
  6. 6.
    Rodrigo R, Bosco C (2006) Oxidative stress and protective effects of polyphenols: comparative studies in human and rodent kidney. A review. Comp Biochem Physiol C Toxicol Pharmacol 142(3–4):317–327PubMedCrossRefGoogle Scholar
  7. 7.
    Bonabi S, Caelers A, Monge A, Huber A, Bodmer D (2008) Resveratrol protects auditory hair cells from gentamicin toxicity. Ear Nose Throat J 87(10):570–573PubMedGoogle Scholar
  8. 8.
    Seidman M, Babu S, Tang W, Naem E, Quirk WS (2003) Effects of resveratrol on acoustic trauma. Otolaryngol Head Neck Surg 129(5):463–470PubMedCrossRefGoogle Scholar
  9. 9.
    Derin A, Agirdir B, Derin N, Dinc O, Guney K, Ozcaglar H et al (2004) The effects of l-carnitine on presbyacusis in the rat model. Clin Otolaryngol Allied Sci 29:238–241PubMedCrossRefGoogle Scholar
  10. 10.
    Ozcaglar HU, Agirdir B, Dinc O, Turhan M, Kilinçarslan S, Oner G (2001) Effects of cadmium on the hearing system. Acta Otolaryngol 121:393–397PubMedCrossRefGoogle Scholar
  11. 11.
    Muldoon LL, Pagel MA, Kroll RA, Brummett RE, Doolittle ND, Zuhowski EG, Egorin MJ, Neuwelt EA (2000) Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity. Clin Cancer Res 6(1):309–315PubMedGoogle Scholar
  12. 12.
    Campbell KCM, Meech RP, Rybak LP, Hughes LF (1999) d-Methionine protects against sisplatin damage to the stria vascularis. Hear Res 138:13–28PubMedCrossRefGoogle Scholar
  13. 13.
    Feghali JG, Liu W, Van De Water TR et al (2001) l-n-Acetyl-cysteine protection against sisplatin-induced auditory neuronal and hair cell toxicity. Laryngoscope 111:1147–1155PubMedCrossRefGoogle Scholar
  14. 14.
    Riggs LC, Matz GJ, Ryback RP (1998) Ototoxicity. In: Bailey BJ, Calhoun KH (eds) Head and neck surgery: otolaryngology, 2nd edn. Lippincott-Raven, Philadelphia, pp 2165–2170Google Scholar
  15. 15.
    Rybak LP, Husain K, Morris C et al (2000) Effect of protective agents against sisplatin ototoxicity. Am J Otol 21:513–520PubMedGoogle Scholar
  16. 16.
    Rubiolo JA, Mithieux G, Vega FV (2008) Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur J Pharmacol 591:66–72PubMedCrossRefGoogle Scholar
  17. 17.
    Li Y, Cao Z, Zhu H (2006) Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress. Pharmacol Res 53:6–15PubMedCrossRefGoogle Scholar
  18. 18.
    Di Franco R, Calvanese M, Murino P et al (2012) Skin toxicity from external beam radiation therapy in breast cancer patients: protective effects of Resveratrol, Lycopene, Vitamin C and anthocianin (Ixor®). Radiat Oncol 30(7):12CrossRefGoogle Scholar
  19. 19.
    Peters RC, Mommersteeg PMC, Heijmen PS (1999) The electroreceptor organ of the catfish, Ictalurus melas, as a model for sisplatin-induced ototoxicity. Neuroscience 91:745–751PubMedCrossRefGoogle Scholar
  20. 20.
    Dehne N, Lautermann J, Petrat F et al (2001) Sisplatin ototoxicity: involvement of iron and enhanced formation of superoxide anion radicals. Toxicol Appl Pharmacol 174:27–34PubMedCrossRefGoogle Scholar
  21. 21.
    Yumusakhuylu AC, Yazici M, Sari M, Binnetoglu A, Kosemihal E, Akdas F, Sirvanci S, Yuksel M, Uneri C, Tutkun A (2012) Protective role of resveratrol against cisplatin induced ototoxicity in guinea pigs. Int J Pediatr Otorhinolaryngol 76(3):404–408PubMedCrossRefGoogle Scholar
  22. 22.
    Erdem T, Bayindir T, Filiz A, Iraz M, Selimoglu E (2011) The effect of resveratrol on the prevention of cisplatin ototoxicity. Eur Arch Otorhinolaryngol 269(10):2185–2188 (Epub ahead of print)PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Gökçe Şimşek
    • 1
    Email author
  • Sibel Alicura Tokgoz
    • 2
  • Erkan Vuralkan
    • 3
  • Murat Caliskan
    • 4
  • Omer Besalti
    • 4
  • Istemihan Akin
    • 5
  1. 1.ENT Clinic, Yesilyurt Hasan Calik State HospitalMinistry of HealthMalatyaTurkey
  2. 2.ENT Clinic, Cankiri State HospitalMinistry of HealthCankiriTurkey
  3. 3.ENT Clinic, Trabzon Numune Research and Training HospitalMinistry of HealthTrabzonTurkey
  4. 4.Surgery Department, Faculty of Veterinary MedicineAnkara UniversityAnkaraTurkey
  5. 5.ENT Clinic, Diskapi Yildirim Beyazit Training and Research HospitalMinistry of HealthAnkaraTurkey

Personalised recommendations